Strategies relying on the local delivery of IL‐10 in situ have been explored for some bacteria, such as L. lactis or Bifidobacterium bifidum in inflammatory bowel disease, with some promising preliminary results in clinical trials (Steidler et al, 2000; Mauras et al, 2018). This evidence concerns the gene IL10 and inflammatory bowel disease.